Comments on: Predictors of pathologic complete response in early-stage triple-negative breast cancer treated with neoadjuvant chemo-immunotherapy
Breast Cancer Research and Treatment · 2026-06 · 217 (3)
DOI: 10.1007/s10549-026-08015-2 ↗Kurz gefasst
Leserbrief in der Zeitschrift Breast Cancer Research and Treatment, online erschienen am 26.06.2026. Verfasst von Rajesh Prasad Jayaswal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Sciences, University Institute of Allied Health Sciences, Chandigarh University, Mohali, Punjab, 140413, India. rpja…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Immunotherapy, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
This correspondence comments on LeVee et al.'s real-world study of neoadjuvant chemo-immunotherapy in early-stage triple-negative breast cancer. We highlight diabetes as a potentially modifiable host-state factor influencing pathologic complete response and propose a metabolic immunotherapy-readiness framework integrating glycaemic control, treatment delivery, endocrine monitoring, and equity-focused implementation. This perspective aims to support globally applicable strategies for improving chemo-immunotherapy effectiveness and access.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Laboratory Sciences, University Institute of Allied Health Sciences, Chandigarh University, Mohali, Punjab, 140413, India. rpjayaswal.jec@gmail.com.
- Uttaranchal Institute of Technology, Uttaranchal University, Dehradun, Uttarakhand, 248007, India.
- Department of Pathology, Govt. Medical College/Rajindra Hospital, Patiala, Punjab, 147001, India.
Zitieren
APA
Jayaswal, R. P., Thapliyal, S., & Badyal, R. K. (2026). Comments on: Predictors of pathologic complete response in early-stage triple-negative breast cancer treated with neoadjuvant chemo-immunotherapy. Breast Cancer Research and Treatment, 217(3). https://doi.org/10.1007/s10549-026-08015-2
Vancouver
Jayaswal RP, Thapliyal S, Badyal RK. Comments on: Predictors of pathologic complete response in early-stage triple-negative breast cancer treated with neoadjuvant chemo-immunotherapy. Breast Cancer Research and Treatment. 2026;217(3). doi:10.1007/s10549-026-08015-2
BibTeX
@article{Jayaswal2026,
author = {Jayaswal, Rajesh Prasad and Thapliyal, Shailendra and Badyal, Rama Kumari},
title = {Comments on: Predictors of pathologic complete response in early-stage triple-negative breast cancer treated with neoadjuvant chemo-immunotherapy},
journal = {Breast Cancer Research and Treatment},
year = {2026},
volume = {217},
number = {3},
doi = {10.1007/s10549-026-08015-2}
}
EUVIMED